Non-Cryopreserved Peripheral Blood Stem Cell Graft for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients

Panarat Noiperm; Jakrawadee Julamanee; Pongtep Viboonjuntra; Arnuparp Lekhakula

doi:10.12659/AOT.938595

17 January 2023: Original Paper

Non-Cryopreserved Peripheral Blood Stem Cell Graft for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients

Panarat Noiperm ^ABCDEF , Jakrawadee Julamanee ^ABCDEFG* , Pongtep Viboonjuntra ^ADE , Arnuparp Lekhakula ^ABCDE

DOI: 10.12659/AOT.938595

Ann Transplant 2023; 28:e938595

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 2 The cumulative incidence function with competing risk regression analyses of relapse and mortality after transplantation. (Stata software, version 17.0, StataCorp LLC, TX, USA).

Back to the Article

Non-Cryopreserved Peripheral Blood Stem Cell Graft for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients

Your Privacy